{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:57:21Z","timestamp":1753876641284,"version":"3.41.2"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,9]]},"abstract":"<jats:p>BCG vaccine may enhance the innate immune response as well as induce a specific immunity against SARS-CoV-2, which may potentially be associated with reduced severity of COVID-19, and may or may not necessarily be protective against SARS-CoV-2 infection. The effect from BCG vaccine was observed even decades after the vaccination.<\/jats:p>","DOI":"10.1093\/jtm\/taaa175","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T19:11:26Z","timestamp":1600283486000},"source":"Crossref","is-referenced-by-count":3,"title":["BCG as an adjunct or alternative vaccine to prevent COVID-19?"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0794-1263","authenticated-orcid":false,"given":"Chien-Hsiang","family":"Weng","sequence":"first","affiliation":[{"name":"Department of Family Medicine, Brown University Warren Alpert Medical School, Providence, RI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brown University Warren Alpert Medical School, Providence, RI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,9,19]]},"reference":[{"volume-title":"COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)","author":"Johns Hopkins University School of Medicine","key":"2020110901125413100_ref1"},{"key":"2020110901125413100_ref2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2020110901125413100_ref3","first-page":"31139-9","article-title":"Activate: randomized clinical trial of BCG vaccination against infection in the elderly","volume":"S0092-8674","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell"},{"key":"2020110901125413100_ref4","doi-asserted-by":"crossref","first-page":"151600","DOI":"10.1016\/j.anndiagpath.2020.151600","article-title":"Strong homology between SARS-CoV-2 envelope protein and a mycobacterium sp. antigen allows rapid diagnosis of mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine","volume":"48","author":"Nuovo","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"2020110901125413100_ref5","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1017\/S0950268820001569","article-title":"Bacillus Calmette-Gu\u00e9rin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study","volume":"148","author":"Weng","year":"2020","journal-title":"Epidemiol Infect"},{"key":"2020110901125413100_ref6","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)","volume":"117","author":"Escobar","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020110901125413100_ref7","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2020.8189","article-title":"SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults","volume":"323","author":"Hamiel","year":"2020","journal-title":"JAMA"},{"key":"2020110901125413100_ref8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","article-title":"BCG-induced trained immunity: can it offer protection against COVID-19?","volume":"20","author":"O'Neill","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2020110901125413100_ref9","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020110901125413100_ref10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine"},{"key":"2020110901125413100_ref11","first-page":"185","article-title":"The efficacy of bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med Indones"},{"key":"2020110901125413100_ref12","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska natives: a 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"JAMA"},{"key":"2020110901125413100_ref13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jinf.2020.08.013","article-title":"Impact of routine infant BCG vaccination in young generation on prevention of local COVID-19 spread in Japan","volume":"81","author":"Kinoshita","year":"2020","journal-title":"J Infect"},{"key":"2020110901125413100_ref14","doi-asserted-by":"crossref","first-page":"100073","DOI":"10.1016\/j.xcrm.2020.100073","article-title":"Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study","volume":"1","author":"Moorlag","year":"2020","journal-title":"Cell Rep Med"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jtm\/advance-article-pdf\/doi\/10.1093\/jtm\/taaa175\/33952881\/taaa175.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jtm\/article-pdf\/27\/7\/taaa175\/34162064\/taaa175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jtm\/article-pdf\/27\/7\/taaa175\/34162064\/taaa175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T06:13:07Z","timestamp":1604902387000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/taaa175\/5908817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,19]]},"references-count":14,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,9,19]]},"published-print":{"date-parts":[[2020,11,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/taaa175","relation":{},"ISSN":["1195-1982","1708-8305"],"issn-type":[{"type":"print","value":"1195-1982"},{"type":"electronic","value":"1708-8305"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,9,19]]},"article-number":"taaa175"}}